Biotech

Close-up image of an intricate, frosty pattern on a glass surface, with a blue hue and varying shapes formed by the frost crystals.

Biotech

Human history has been all but defined by death and disease, plague and pandemic. Advancements in 20th century medicine changed all of that. Now advancements in 21st century medicine promise to go even further. Could we bring about an end to disease? Reverse aging? Give hearing to the deaf and sight to the blind? The answer may be yes. And soon.
Featured
The missing tech case for how we create an era of abundance
AI and other new technologies could make things that are costly and scarce today, cheap and abundant for all tomorrow.
The next era of psychedelics may be precision-designed states of consciousness
A look inside Mindstate Design Labs’ effort to design drugs that reliably produce specific states of consciousness.
What is The Great Progression: 2025 to 2050?
We have a historic opportunity to harness AI and other transformative technologies in order to make a much better world in the next 25 years.
Psychedelics & Mental Health
How to reclaim meaning in a changing world
What if the barrier to a fulfilled life isn’t technology, it’s culture?
The exciting research that may cure Parkinson’s 
GeneCode is developing a drug it hopes won’t just alleviate Parkinson’s symptoms but also protect and restore patient’s neural health.
Biohacking
We’re able to create new creatures through gene editing. What’s stopping us?
The question isn’t whether we can sculpt new life. The question is what comes next.
Boosted Breeding and beyond: 3 tech trends that could end world hunger
A world without hunger is possible, and the development and deployment of new farming technologies could be one key to manifesting it.
New AI generates CRISPR proteins unlike any seen in nature
An AI that generates CRISPR proteins is opening the door to gene editors with capabilities beyond what we’ve found in nature.
Ray Kurzweil explains how AI makes radical life extension possible
Life expectancy gains in developed countries have slowed in recent decades, but AI may be poised to transform medicine as we know it.
Vaccines
Personalized cancer vaccines are having a moment
Personalized cancer vaccines were a recurring theme at the annual meeting of the American Association for Cancer Research in 2024.
The threat of avian flu — and what we can do to stop it
Avian flu is infecting cows on US dairy farms, and now a person has caught it — but new research could help us avoid a bird flu pandemic.
One shot recreates younger immune systems, in mice
An antibody treatment designed to revitalize an aging immune system delivers “surprising” results in elderly mice.
More
Neuralink’s monkey can play Pong with its mind. Elon Musk says human trials are next.
If Neuralink’s monkey can play Pong with its mind, imagine what humans could do with the same technology in just a few years.
Generate brilliant ideas by relaxing your cognitive filters
Theoretical physicist Leonard Mlodinow offers three strategies for relaxing your cognitive filters to give your brilliant ideas time to shine.
Cancer med appears to prevent brain aneurysms
Japanese researchers have discovered that the cancer drug sunitinib can prevent the formation of brain aneurysms in mice.
SpaceX successfully launches world’s first “space factory”
SpaceX has successfully deployed a “space factory” developed by startup Varda Space Industries to manufacture drugs in microgravity.
How intestinal viruses could help you live to be 100
People who live past age 100 have a greater diversity of bacteriophages (that is, viruses that infect bacteria) in their intestines.
Model human embryo, created from stem cells, survives past two weeks
A model human embryo capable of developing past day 14 could revolutionize our understanding of human development.
Cheap drug appears to cut long COVID risk by 41% in small study
The diabetes drug metformin cut COVID-19 patients’ risk of later developing long COVID by 41% in a small study.
Taurine appears to reverse aging in animals. Can it do the same for us?
Animals given taurine lived longer, healthier lives, suggesting that the compound may also increase human longevity.
New “AI doctor” predicts risk of death with 85% accuracy
A new AI was able to make accurate predictions about patients’ risk of death, readmittance, and more by analyzing medical notes.
Have we got the brain all wrong? Study shows its shape is more important than its wiring
Neural activity may be more influenced by the shape of the brain – its grooves, contours, and folds – than by its complex interconnections.
Flexible brain implant tested in people for the first time
Startup Precision Neuroscience has tested its flexible, ultra-thin brain implants in people for the first time.
90% of patients respond to new blood cancer treatment in trial
Israeli researchers have developed a new form of CAR-T therapy effective against multiple myeloma, a plasma cell cancer.
Brain scans hint that lonely individuals process the world differently
A study finds that the brains of people who score higher in loneliness react in unique ways when viewing video content.
Visiting space likely won’t cause permanent brain damage, says NASA study
Spending months in space has a major impact on astronauts’ brains, but three years back on Earth appears to reverse the change.
Made-to-fade tattoo ink keeps cancer therapy from leaving a mark
Henry Ford Health researchers are using temporary tattoo ink to help radiation therapy patients for whom permanent tattoos may not be an option.
Scientists are growing animals in artificial wombs. Humans might be next.
Artificial wombs promise to give people a way to have biological children without putting their own health at risk.
The neurons that make us feel hangry
Researchers gave pinpointed a cluster of cells called AgRP neurons near the underside of the brain that may create “hangry” feelings.
New drug for fatty liver disease cuts fat by 65%
A new NASH treatment, efruxifermin, significantly reduced liver fat when combined with a GLP-1 drug in a small trial.
Lung cancer drug slashes patients’ risk of death by 51%
Osimertinib, an FDA-approved lung cancer drug, slashes the risk of death for certain patients by 51%, according to new trial results.
Special Collection
Collection
The Science of Death
Explore the journey from life to death and beyond. Near-death experiences, death doulas, digital immortality, and more – join us for a thoughtful exploration of one life’s most intriguing and inevitable phenomena with stories from the frontlines of death.
Subscribe to the newsletter